Specifically to be included was a list of literature most pertinent to an evaluation of the effectiveness of the drug[s] for the purposes for which [they were] offered in the label, package insert, or brochure and any unpublished articles or other data pertinent to an evaluation of the claims. 31 Fed.Reg. 13014-15, (October 6, 1966.)